Varaico: Literature-Extracted Genetic Variants

Gene:TARDBP
Variant:p.F147L
Back to variants list

TARDBP

NM_007375.4:p.F147L

Associated Papers

Defining RNA oligonucleotides that reverse deleterious phase transitions of RNA-binding proteins with prion-like domains.

Guo L et al.

Molecular Cell, 2026

J-domain proteins cooperate with Hsp70 to drive multiphase separation of RNA-binding-deficient TDP-43.

Yeo KH et al.

The Journal of Biological Chemistry, 2025

RNA helicase maheshvara interacts with TDP-43 and exacerbates neurodegeneration in Drosophila model of amyotrophic lateral sclerosis.

Pandey P et al.

Neurobiology of Disease, 2025

Critical impact of lysine 136 in TDP-43 phase separation, compartmentalization, and aggregation in living vertebrates.

Maurel C et al.

Iscience, 2025

SUMO2/3 conjugation of TDP-43 protects against aggregation.

Verde EM et al.

Science Advances, 2025

Decoding Missense Variants by Incorporating Phase Separation via Machine Learning.

Feng M et al.

Nature Communications, 2024

39333476 (PubMed )
Supplement: 41467_2024_52580_MOESM4_ESM.xlsx › impact_ps_mutations

RNA-binding properties orchestrate TDP-43 homeostasis through condensate formation in vivo.

Scherer NM et al.

Nucleic Acids Research, 2024

Establishing mRNA and microRNA interactions driving disease heterogeneity in amyotrophic lateral sclerosis patient survival.

Waller R et al.

Brain Communications, 2024

TDP-43 Epigenetic Facets and Their Neurodegenerative Implications.

Gimenez J et al.

International Journal of Molecular Sciences, 2023

Defining RNA oligonucleotides that reverse deleterious phase transitions of RNA-binding proteins with prion-like domains.

Guo L et al.

Biorxiv : the Preprint Server for Biology, 2023

Aggregation-prone TDP-43 sequesters and drives pathological transitions of free nuclear TDP-43.

Keating SS et al.

Cellular and Molecular Life Sciences : Cmls, 2023

Nuclear RNA binding regulates TDP-43 nuclear localization and passive nuclear export.

Duan L et al.

Cell Reports, 2022

35858577 (PubMed )
Supplement: NIHMS1825578-supplement-1.pdf

TDP-43 pathology: From noxious assembly to therapeutic removal.

Keating SS et al.

Progress in Neurobiology, 2022

RNA-assisted sequestration of RNA-binding proteins by cytoplasmic inclusions of the C-terminal 35-kDa fragment of TDP-43.

Jiang LL et al.

Journal of Cell Science, 2022

Sirtuin-1 sensitive lysine-136 acetylation drives phase separation and pathological aggregation of TDP-43.

Garcia Morato J et al.

Nature Communications, 2022

Sequence Determinants of TDP-43 Ribonucleoprotein Condensate Formation and Axonal Transport in Neurons.

Vishal SS et al.

Frontiers in Cell and Developmental Biology, 2022

TDP-43 stabilizes G3BP1 mRNA: relevance to amyotrophic lateral sclerosis/frontotemporal dementia.

Sidibé H et al.

Brain : a Journal of Neurology, 2021

Exploring the molecular basis of UG-rich RNA recognition by the human splicing factor TDP-43 using molecular dynamics simulation and free energy calculation.

Sun H et al.

Journal of Computational Chemistry, 2021

TDP-43 aggregation induced by oxidative stress causes global mitochondrial imbalance in ALS.

Zuo X et al.

Nature Structural & Molecular Biology, 2021

TDP-43 α-helical structure tunes liquid-liquid phase separation and function.

Conicella AE et al.

Proceedings of the National Academy of Sciences of the United States of America, 2020

Splicing repression is a major function of TDP-43 in motor neurons.

Donde A et al.

Acta Neuropathologica, 2019

C9-ALS/FTD-linked proline-arginine dipeptide repeat protein associates with paraspeckle components and increases paraspeckle formation.

Suzuki H et al.

Cell Death & Disease, 2019

Detection of TAR DNA-binding protein 43 (TDP-43) oligomers as initial intermediate species during aggregate formation.

French RL et al.

The Journal of Biological Chemistry, 2019

An Intramolecular Salt Bridge Linking TDP43 RNA Binding, Protein Stability, and TDP43-Dependent Neurodegeneration.

Flores BN et al.

Cell Reports, 2019

TDP-43 misexpression causes defects in dendritic growth.

Herzog JJ et al.

Scientific Reports, 2017

Genetic mutations in RNA-binding proteins and their roles in ALS.

Kapeli K et al.

Human Genetics, 2017

Regulatory Role of RNA Chaperone TDP-43 for RNA Misfolding and Repeat-Associated Translation in SCA31.

Ishiguro T et al.

Neuron, 2017

Heat Shock-induced Phosphorylation of TAR DNA-binding Protein 43 (TDP-43) by MAPK/ERK Kinase Regulates TDP-43 Function.

Li W et al.

The Journal of Biological Chemistry, 2017

TBPH/TDP-43 modulates translation of Drosophila futsch mRNA through an UG-rich sequence within its 5'UTR.

Romano M et al.

Brain Research, 2016

From animal models to human disease: a genetic approach for personalized medicine in ALS.

Picher-Martel V et al.

Acta Neuropathologica Communications, 2016

Nuclear TDP-43 causes neuronal toxicity by escaping from the inhibitory regulation by hnRNPs.

Suzuki H et al.

Human Molecular Genetics, 2015

TDP-43 suppresses CGG repeat-induced neurotoxicity through interactions with HnRNP A2/B1.

He F et al.

Human Molecular Genetics, 2014

Binding of TDP-43 to the 3'UTR of its cognate mRNA enhances its solubility.

Sun Y et al.

Biochemistry, 2014

The crystal structure of TDP-43 RRM1-DNA complex reveals the specific recognition for UG- and TG-rich nucleic acids.

Kuo PH et al.

Nucleic Acids Research, 2014

Molecular basis of UG-rich RNA recognition by the human splicing factor TDP-43.

Lukavsky PJ et al.

Nature Structural & Molecular Biology, 2013

Spliceosome integrity is defective in the motor neuron diseases ALS and SMA.

Tsuiji H et al.

Embo Molecular Medicine, 2013

Inhibition of TDP-43 aggregation by nucleic acid binding.

Huang YC et al.

Plos One, 2013

Cellular model of TAR DNA-binding protein 43 (TDP-43) aggregation based on its C-terminal Gln/Asn-rich region.

Budini M et al.

The Journal of Biological Chemistry, 2012

TDP-43 regulates global translational yield by splicing of exon junction complex component SKAR.

Fiesel FC et al.

Nucleic Acids Research, 2012

Alteration of POLDIP3 splicing associated with loss of function of TDP-43 in tissues affected with ALS.

Shiga A et al.

Plos One, 2012

TDP-43 is a transcriptional repressor: the testis-specific mouse acrv1 gene is a TDP-43 target in vivo.

Lalmansingh AS et al.

The Journal of Biological Chemistry, 2011

TDP-43 regulates Drosophila neuromuscular junctions growth by modulating Futsch/MAP1B levels and synaptic microtubules organization.

Godena VK et al.

Plos One, 2011

TDP-43-mediated neuron loss in vivo requires RNA-binding activity.

Voigt A et al.

Plos One, 2010

Functional mapping of the interaction between TDP-43 and hnRNP A2 in vivo.

D'Ambrogio A et al.

Nucleic Acids Research, 2009

Structural determinants of the cellular localization and shuttling of TDP-43.

Ayala YM et al.

Journal of Cell Science, 2008

1–50 of 51 papers
Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."